Idorsia Ltd
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Idorsia Ltd
Idorsia Ltd is a biopharmaceutical company engaged in discovering, developing, and commercializing of medicines for unmet medical needs. It is a biotech hub of Europe specialized in the discovery and development of small molecules, to provide new therapeutic options. The company focuses on multiple therapeutic areas which include the central nervous system, cardiovascular disorders, immunological disorders, and orphan diseases. Idorsia's development compounds target a number of different diseases such as Resistant Hypertension, lupus, insomnia, Cerebral vasospasm, and Fabry disease. Geographically, it derives revenue from Switzerland.
/ 
Frequently asked questions
To buy Idorsia Ltd stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Idorsia Ltd by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Idorsia Ltd is IDIA:xswx. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Idorsia Ltd has its primary listing on SIX Swiss Exchange. You can trade Idorsia Ltd with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Idorsia Ltd is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Idorsia Ltd as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Idorsia Ltd.